Margaret T. Fox, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2215 Dutch Gold Dr, Lancaster, PA 17601 Phone: 717-569-8972 Fax: 717-569-7762 |
Sara Lynn Krause Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 248 Granite Run Dr, Lancaster, PA 17601 Phone: 717-560-2917 Fax: 717-560-2985 |
Mrs. Gina M Randazzo, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 625 Community Way, Lancaster, PA 17603 Phone: 717-393-0425 Fax: 717-392-7107 |
Megan L Clark, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2215 Dutch Gold Dr, Lancaster, PA 17601 Phone: 717-569-8972 Fax: 717-569-7762 |
Lancaster Cleft Palate Clinic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 223 N Lime St, Lancaster, PA 17602 Phone: 717-394-3793 |
Tara Lynn Dombach, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 E King St, Lancaster, PA 17602 Phone: 717-293-7279 Fax: 717-735-3106 |
Margaret Young Nicholas, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hillcrest Rd, Lancaster, PA 17603 Phone: 717-951-8311 |
Ms. Ashley Elizabeth Sobota Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 E King St, Lancaster, PA 17602 Phone: 717-299-7279 Fax: 717-392-5118 |
Mrs. Roberta T. Kornfield, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2215 Dutch Gold Dr, Lancaster, PA 17601 Phone: 717-569-8972 Fax: 717-569-7762 |
Brandi Nicole Gilliland Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2001 Harrisburg Pike, Lancaster, PA 17601 Phone: 717-735-2606 |
Kristine Erin Van Tassel, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2137 Embassy Dr, Suite 103, Lancaster, PA 17603 Phone: 717-569-8972 |
Mrs. Stacie Lynn Rexroad-cole, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 Village Cir, Lancaster, PA 17603 Phone: 717-509-8270 |
Ms. Kristen Seiz, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 E King St, Lancaster, PA 17602 Phone: 717-299-7877 |
Karen Dorothy Blackburn, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1020 New Holland Ave, Lancaster, PA 17601 Phone: 717-606-1865 Fax: 717-606-1995 |
Lisa Stumpp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 755 Summit Dr, Lancaster, PA 17601 Phone: 717-614-3485 |
Judith Anne Milgram, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 E King St, Lancaster, PA 17602 Phone: 717-299-7877 |
Carrie M Ruggiero, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2160 Noll Dr, Suite 200, Lancaster, PA 17603 Phone: 717-481-8720 Fax: 717-481-8726 |
Katie L Woods, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 625 Community Way, Lancaster, PA 17603 Phone: 717-393-0425 Fax: 717-735-6009 |
Mr. Anthony Micheal Freeman, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 71 Hershey Ave, Lancaster, PA 17603 Phone: 717-615-6253 |
Mrs. Dorlas L Riley, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 625 Community Way, Lancaster, PA 17603 Phone: 717-393-0425 Fax: 717-392-7107 |
News Archive
pSivida Corp., a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grants were awarded to pSivida to help fund further research on new generations of the company's drug delivery technologies targeting ophthalmic diseases.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.
Whether a creature is a worm, a fly, a mouse, or a human, death inevitably awaits. And not only do these organisms share a common fate, but also, according to a new study, they may share some of the specific mechanisms of mortality. The researchers found that in all four species, there are 46 genes regulated by the same family of "FOXO" proteins known to be central in aging and longevity.
News outlets also report that e-brokers cannot offer exchange plans right away, and that some people may try to use the online marketplaces to mislead consumers.
› Verified 5 days ago